PT Murni Sadar Tbk (“the Company”, Murni Teguh Hospitals”) is a health service provider with a focus on oncology and cardiovascular as well as a health education center. As of 31 December 2022, the Company managed 7 hospitals in various areas in Medan, Jakarta, Bali, Tangerang, Pematangsiantar and Pekanbaru. This number will continue to grow in line with the Company's goal of providing health services that are closer to the community. Until the end of 2022, 5 out of 7 hospitals managed by the Company have been fully accredited by the Hospital Accreditation Committee (KARS) and will be followed by other hospitals. The company has successfully carried out an initial public offering on the Indonesia Stock Exchange on April 20, 2021 with the stock code MTMH.

1. Onkologi
   1. Chemotherapy
   2. Radiotherapy (2 unit Linac dan 1 Unit Brachitherapy)
2. Kardiovaskular
   1. Open Hearth Surgery
   2. Cathlab (3 unit)
   3. PCI
   4. Pediatric Intervention
   5. Echocardiography
   6. EKG
   7. Treadmill
3. CT Scan (6 unit)
4. ESWL (2 unit)
5. MRI (2 unit)
6. Mesin Hemodialisa (98 unit)

Murni Teguh Hospitals will have a capacity of 1,035 beds supported by more than 400 medical staff and more than 1,900 nurses and support staff in order to provide quality health services by prioritizing patient safety.

Articles of Association

Articles of Association of PT Murni Sadar Tbk

1. Akte Pendirian No. 01 Tanggal 01 September 2010
2. Akte Risalah Rapat No. 76 Tanggal 28 Februari 2012
3. Akte Pernyataan Keputusan Rapat No. 130 Tanggal 27 Desember 2012
4. Akte Pernyataan Keputusan Rapat No. 58 Tanggal 27 Januari 2014
5. Akte Pernyataan Keputusan Rapat No. 139 Tanggal 27 Desember 2017
6. Akte Pernyataan Keputusan Rapat No. 61 Tanggal 27 November 2020
7. Akte Pernyataan Keputusan Rapat No. 76 Tanggal 28 Oktober 2021
8. Akte Pernyataan Keputusan Para Pemegang Saham No. 78 Tanggal 29 Oktober 2021
9. Akte Pernyataan Keputusan Para Pemegang Saham No. 32 Tanggal 17 Desember 2021
10. Akte Perubahan Anggaran Dasar No. 33 Tanggal 17 Desember 2021

Corporate Social Responsibilty

Investor Relations Contact

Email *

Full Name *

Country

Company

Pesan

Corporate Secretary Appointment Decree

Internal audit unit charter

Audit Committee Charter

Nomination and Remuneration Committee Guidelines

Board of Commissioner Charter

Board of Director Charter

Principles of Good Corporate Governance

Risk Management

Responsibilities of the Board of Commissioners

Duties and Responsibilities of the Board of Directors

Dividend Policy

Shareholders' Rights

Dividend Payment History

Decree of Appointment and Changes to the Nomination and Remuneration Committee

Decree of Appointment of the Audit Committee

What is a Whistleblowing System?

Report

Criteria

Complainable Violations

• Violations of corporate ethics such as corruption, gratuities, conflicts of interest, extortion, etc
• Violations related to company regulations
• Violations related to operational policies and procedures
• Violations related to laws and regulations
• Violations related to actions that endanger work safety

Reporting Procedures

Whistleblowing System Policies and Procedures

Reporting Form

Reporting Data

Are you willing to reveal your identity? *

Yes No

Please Select one of the option

Reporter Email *

Please enter your email

Complainant's Full Name *

Please enter your name

Reporting Phone Number *

Please enter phone number

Reporting address *

Please enter your address

Problem Data

Complained Issues *

-- Select Problem --

Please enter your issues

Location of the incident *

-- Select Location --

Please enter location of the incident

Estimated Date of Event *

Please enter estimated date of event

Estimated Time of Event *

Please enter estimated time of event

Involved Parties *

Please enter involved parties

Total Loss *

Please enter total loss

Detail Chronology of Events *

Please enter detail chronology of events

Report Supporting Data/Files

Supporting Files *

Please input supporting files

File Total Size 5 MB Max

Only support .jpg .png .pdf extension

Prospectus

Net Profit Growth

Press Release

Investor Information

Composition of Shareholders

Shareholder Structure

Financial Summary

Financial Statement

Financial Report as of December 31, 2021

Financial Report as of June 30, 2022

Financial Report as of December 31, 2022

Financial Report as of March 31, 2023

Financial Report as of June 30, 2023

Financial Report as of September 30, 2023

Financial Report as of December 31, 2023

Financial Report as of March 31, 2024

Financial Report as of June 30, 2024

Financial Report as of September 30, 2024

Annual General Meeting

2022

• Announcement of AGMS
• Invitation of AGMS
• Agenda of AGMS
• Code of Conduct AGMS
• AGMS Power of Attorney
• Annual GMS Summary

2023

• Announcement of AGMS
• Invitation of AGMS
• Agenda of AGMS
• Code of Conduct AGMS
• AGMS Power of Attorney
• Annual GMS Summary

2024

• Announcement of AGMS and EGMS
• Invitation of AGMS and EGMS
• Agenda of AGMS and EGMS
• Code of Conduct AGMS and EGMS
• AGMS and EGMS Power of Attorney
• AGMS and EGMS Summary
• Announcement of EGMS
• Invitation of EGMS
• Agenda of EGMS
• Curriculum Vitae of Tjhin Ten Chun
• Curriculum Vitae of dr. Andi Wahyuningsih Attas, Sp.An., KIC., MARS
• Curriculum Vitae of DR. dr. Mutiara, MHA, MKT
• Curriculum Vitae of dr. Jong Khai, MARS
• Curriculum Vitae of Clement Zichri Ang, M.Sc
• Curriculum Vitae of Felix Vincent Ang, B.Eng
• GMS Power of Attorney
• EGMS Summary

Annual report

• 2021
• 2022
• 2023